LMAT LeMaitre Vascular, Inc.
Healthcare$98.19+0.00%OpenMarket Cap: $2.24B
As of 2026-05-26
Valuation
P/E (TTM)
45.22
PEG
1.45
P/B
5.48
P/S
8.72
EV/EBITDA
26.49
DCF Value
$89.15
FCF Yield
3.5%
Div Yield
0.9%
Margins & Returns
Gross Margin
72.4%
Operating Margin
28.5%
Net Margin
24.3%
ROE
16.2%
ROA
9.9%
ROIC
9.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $66.6M | 72.7% | $17.8M | $15.7M | $— | $0.25 |
| Q4 null | $64.5M | 71.7% | $18.8M | $15.6M | $— | $0.20 |
| FY null | $249.6M | 71.5% | $67.9M | $57.7M | $— | $0.80 |
| Q3 null | $61.0M | 75.3% | $20.3M | $17.4M | $— | $0.20 |
| Q2 null | $64.2M | 70.0% | $16.1M | $13.8M | $— | $0.20 |
| Q1 null | $59.9M | 69.2% | $12.6M | $11.0M | $— | $0.20 |
| Q4 null | $55.7M | 69.3% | $12.9M | $11.2M | $— | $0.16 |
| FY null | $219.9M | 68.6% | $52.3M | $44.0M | $— | $0.64 |
| Q3 null | $54.8M | 67.8% | $13.1M | $11.1M | $— | $0.16 |
| Q2 null | $55.8M | 68.9% | $14.4M | $11.8M | $— | $0.16 |
| Q1 null | $53.5M | 68.6% | $11.9M | $9.9M | $— | $0.16 |
| Q4 2023 | $48.9M | 68.1% | $10.2M | $8.5M | $0.38 | $0.14 |